SMTL ID : 7a6c.1

Nanodisc reconstituted human ABCB1 in complex with MRK16 Fab and elacridar

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-1-mer

Ligands

2 x R0Z: elacridar(Non-covalent)

R0Z.1: 11 residues within 4Å: Chain A: L.65, M.69, F.336, Q.725, F.728, F.732, Y.953, S.979, F.983, M.986 Ligands: R0Z.2 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:F.336, A:F.732, A:F.983 Hydrogen bonds: A:Y.953 pi-Stacking: A:F.983 R0Z.2: 11 residues within 4Å: Chain A: W.232, L.236, F.239, I.299, F.303, I.306, Y.310, F.343, F.770, F.994 Ligands: R0Z.1 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:W.232, A:L.236, A:F.303, A:I.306 Hydrogen bonds: A:Y.310 pi-Stacking: A:F.239, A:F.994

10 x CLR: CHOLESTEROL(Non-covalent)

CLR.3: 6 residues within 4Å: Chain A: L.860, I.864, R.958, F.959 Ligands: CLR.5, CLR.12 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:L.860, A:I.864, A:F.959, A:F.959 CLR.4: 3 residues within 4Å: Chain A: Q.856, L.859, F.959 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:L.859, A:F.959 CLR.5: 2 residues within 4Å: Chain A: A.863 Ligands: CLR.3 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:A.863 CLR.6: 11 residues within 4Å: Chain A: L.305, A.308, A.311, L.312, W.315, N.753, S.756, L.757, L.760 Ligands: CLR.8, CLR.9 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.305, A:A.308, A:L.312, A:W.315, A:L.757 Hydrogen bonds: A:N.753 CLR.7: 3 residues within 4Å: Chain A: V.217, A.220 Ligands: CLR.8 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:V.217, A:A.220 CLR.8: 6 residues within 4Å: Chain A: I.221, V.224, L.312 Ligands: CLR.6, CLR.7, CLR.9 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:I.221, A:L.312 CLR.9: 3 residues within 4Å: Chain A: W.315 Ligands: CLR.6, CLR.8 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:W.315 CLR.10: 4 residues within 4Å: Chain A: I.836, N.839, I.840 Ligands: CLR.11 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:I.836, A:N.839, A:I.840 Hydrogen bonds: A:R.832 CLR.11: 8 residues within 4Å: Chain A: I.847, V.865, P.866, A.869, I.870, V.873, S.992 Ligands: CLR.10 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:I.847, A:V.865, A:P.866, A:I.870, A:V.873 Hydrogen bonds: A:S.992, A:S.992 CLR.12: 2 residues within 4Å: Chain A: F.951 Ligands: CLR.3 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:F.951

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Nosol, K. et al., Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1. Proc.Natl.Acad.Sci.USA (2020)

Release Date

2020-10-14

Peptides

Multidrug resistance protein 1: A
If kappa light chain: B
MRK16 Fab-fragment heavy chain: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Multidrug resistance protein 1

If kappa light chain

MRK16 Fab-fragment heavy chain

Related Entries With Identical Sequence